Background-Although histopathologic studies suggest persistent myocardial abnormalities after Kawasaki disease (KD), the long-term effects on cardiac function remain to be revealed. We investigated biventricular volumes, function, and the presence of myocardial fibrosis by cardiac magnetic resonance imaging during long-term follow-up of KD. Methods and Results-Sixty patients with a history of KD (mean age, 16.9 years; 67% men; median interval after KD onset, 11.6 years) and 20 healthy control subjects (mean age, 17.9 years; 55% men) 12 to 24 years of age underwent cardiac magnetic resonance imaging. Biventricular end-diastolic volume, end-systolic volume, stroke volume, and ejection fraction were determined. Volumetric measurements were indexed for body surface area. Late contrast enhancement was used to detect areas of myocardial fibrosis. Biventricular volumes and function did not differ significantly between patients and control subjects. There were also no significant differences between patients with and without a history of left ventricular dysfunction resulting from KD-associated myocarditis or between patients with and without coronary artery aneurysms.
K awasaki disease (KD) is an acute systemic vasculitis that occurs predominantly in children <5 years of age. First reported in 1967 in Japan, KD has now been described worldwide in all racial and ethnic groups. 1 Coronary artery aneurysms (CAAs) develop in 15% to 25% of untreated cases. The incidence of CAAs has been decreased to <10% of patients as a result of treatment with high-dose intravenous immunoglobulins (IVIG). 2, 3 In approximately half of the cases, CAAs persist and may lead to ischemic heart disease, myocardial infarction, or sudden death.
Left ventricular (LV) dysfunction secondary to myocarditis is a well-recognized cardiovascular complication during the acute phase. [4] [5] [6] [7] In the past, myocardial inflammation has been documented in up to 50% to 70% of patients early in the KD course with the use of different diagnostic methods. [8] [9] [10] This finding has been supported by autopsy and biopsy studies showing that almost all patients had some signs of myocarditis, pericarditis, or valvulitis. 11, 12 Persistent myocardial abnormalities up to >10 years after disease onset have been observed in specimens of the right ventricular (RV) myocardium. 12 Consistent with the pathological findings, echocardiographic long-term abnormalities of LV size and function were reported. 4 Subsequent echocardiographic studies have reported normalization of myocardial function during reconvalescence, most likely because of IVIG treatment. 5, 7 Although LV dysfunction is a well-known feature of the acute phase, investigations of the long-term effects on cardiac function are limited and have produced conflicting results. Cardiovascular magnetic resonance imaging (CMRI) has been shown to be an accurate and reproducible method for noninvasive assessment of both LV and RV function. [13] [14] [15] CMRI is the reference standard for the assessment of biventricular function. 16 Furthermore, CMRI late contrast enhancement is the best method to detect nonviable January 2013 or inflamed myocardium caused by myocardial infarction, myocarditis, or other nonischemic heart disease. 17, 18 At present, CMRI is routinely used to diagnose and follow up myocarditis and to distinguish myocarditis from myocardial infarction.
The aim of our study was to evaluate biventricular volumes and function at long-term follow-up of KD patients using CMRI and to compare the results with healthy subjects. In addition, we investigated the presence of myocardial fibrosis by late contrast enhancement in patients with KD, and in a subset of patients, a follow-up CMRI was performed after a minimal interval of 6 months.
Methods

Subjects
This study was conducted between January 2008 and October 2011 at the multidisciplinary KD outpatient department of the Emma Children's Hospital, a tertiary referral center. Sixty patients (age, 12-24 years) with a history of KD, according to the diagnostic criteria of the American Heart Association, 3 were included in consecutive order of outpatient consultation. CMRIs were repeated in 15 randomly selected patients after a minimal interval of 6 months to evaluate possible changes over time. During the study period, 20 healthy volunteers (age, 12-24 years) were also examined. These healthy subjects had no history of cardiovascular disease and received no medications. Exclusion criteria for the study were contraindications for MRI scanning. The study was approved by our institution's ethics committee, and written informed consent was obtained.
Clinical Information
Clinical information was collected retrospectively from medical records and included the following: time of disease onset, treatment, admission to the pediatric intensive care unit, presence of LV dysfunction on echocardiography (defined as shortening fraction <28%), and CAA status. CAAs were defined according to criteria established by the Japanese Ministry of Health in 1984. 19 
Cardiac Magnetic Resonance Imaging
Examinations were performed by an experienced operator using a 1.5-T whole-body MRI scanner equipped with cardiac software (Avanto, Siemens, Erlangen, Germany). Imaging was performed with the subject in the supine position with a cardiac phased-array coil and a vectorcardiographic method for ECG gating. After a series of thoracic scout images that were used for planning, short-axis views consisting of 12 to 14 contiguous slices were acquired covering both ventricles from the base of the heart to the apex using a steady-state free precession sequence. Scan parameters were as follows: repetition time=3.2 to 3.8 milliseconds; echo time=1.6 to 1.9 milliseconds; flip angle=50° to 70°; slice thickness=6 mm without slice gap; matrix=160×256; and field of view=350 to 400 mm. Temporal resolution was ≈25 milliseconds. All studies were obtained during breath hold in end expiration. The image was repeated in case of unsuccessful breath hold. The imaging protocol was extended to evaluate late contrast enhancement in the patients. Inversion recovery TurboFLASH was performed in 2-chamber, 3-chamber, 4-chamber, and short-axis views 5 to 15 minutes after infusion of intravenous contrast (gadolinium at a dose of 0.2 mmol/kg).
CMRIs were repeated in 15 randomly selected patients after a minimal interval of 6 months. The first CMRI was included for comparison of patients and control subjects. The follow-up CMRI was used for comparison with the first CMRI.
CMRI Analysis
LV and RV volumes and function were analyzed with the software package MASS (Medis, Leiden, the Netherlands). Biventricular endocardial contours were outlined at end systole and end diastole in all sections. 20 Papillary muscles were not excluded from the ventricular volumes. Biventricular end-diastolic volumes (EDVs) and end-systolic volumes (ESVs) were obtained. Stroke volumes were calculated by subtracting ESV from EDV, and ejection fraction (EF) was calculated by dividing stroke volumes by EDV and multiplying by 100%. All CMRIs were analyzed by 1 experienced observer (S.R.) who was blinded to the clinical information. To assess intraobserver variability, 10 randomly selected studies were reanalyzed after a minimal period of 3 months. For interobserver variability, a second observer (M.G.) analyzed the same 10 studies independently while blinded to the previous results.
Late contrast-enhanced images were evaluated visually for myocardial areas of enhancement through the use of a 17-segment model. 21, 22 Areas of late enhancement were categorized as subendocardial, transmural, subepicardial, or midwall. Both observers evaluated the late contrast-enhanced images independently. They were unaware of each other's results.
Statistics
All statistical analyses were performed with the SPSS software package version 19.0. Data are expressed as mean±SD unless otherwise indicated. Demographic characteristics between patients and control subjects were evaluated by the use of χ 2 tests for categorical variables and independent-sample t tests for continuous variables with a normal distribution. Biventricular dimensions were divided by body surface area (BSA) to obtain adjusted values. BSA was calculated according to the Mosteller formula: √height (cm)×weight (kg)/3600. The effect of age and sex was taken into account through multivariable linear regression analysis when comparing biventricular dimensions of patients and control subjects, and subgroups of patients. For subgroup analyses, patients were divided on the basis of CAA status, presence of ischemic heart disease, and history of LV dysfunction during the acute phase. Paired t tests were used to compare the results of both CMRIs of patients who underwent CMRI reexamination. Intraobserver and interobserver variabilities were assessed with the intraclass correlation coefficient and Bland-Altman method. 23 The coefficient of variation, that is, the SD of the difference of the 2 measurements divided by the grand mean of the whole sample, expressed as a percentage, was calculated to study variability of the measurements. Values of P<0.05 were considered statistically significant.
Results
Demographic and Clinical Characteristics
Sixty patients (mean age, 16.9±3.6 years; 67% men) and 20 healthy control subjects (mean age, 17.9±3.5 years; 55% men) were included. None of the study subjects had to be excluded because of MRI contraindications. Table 1 summarizes the demographic characteristics of the included patients and control subjects. There were no significant differences between the 2 groups. Clinical characteristics of the patients are given in Table I in the online-only Data Supplement. Patients were diagnosed with KD at a median age of 3.9 years (range, 0.1-16.4 years), and the median interval to CMRI examination was 11.6 years (range, 0.6-20.7 years). In total, 53 patients (88%) had been treated with IVIG, and 6 of these patients had received IVIG retreatment. In the 7 patients not treated with IVIG, the diagnosis was missed (n=1) or recognized too late (n=6). In 2 patients, steroids had also been administered. Eight patients (13%) had been documented with a diminished ventricular shortening fraction by echocardiography during the acute phase; 3 of these 8 patients had been admitted to the pediatric intensive care unit because of circulatory failure. During reconvalescence, all 8 patients had clinically recovered completely and LV dysfunction had normalized as determined by echocardiography. In total, 19 patients were diagnosed with CAAs, and 9 of these 19 patients are known to have persistent CAAs. Five patients had previously been diagnosed with myocardial ischemia and treated with coronary artery bypass grafting because of severe coronary lesions.
CMRI Results
Biventricular CMRI results are presented in Table 1 . No significant differences were found between patients and control subjects. In subgroup analysis, no significant differences were observed between patients with and without persistent CAAs or between patients with and without a history of LV dysfunction ( Table 2) . When we compared patients with CAAs during the acute phase (n=19) with those without CAAs during the acute phase (n=41), no differences were found (data not shown).
In the 5 patients with a history of ischemic heart disease or coronary artery bypass grafting procedure because of severe coronary lesions, LVESV was significantly larger (53±6 versus 41±7 mL/m 2 ; P=0.023) and LVEF was significantly smaller (52% versus 57%; P=0.012) compared with the remaining patients. LVEDV did not differ significantly (110±10 versus 96±13 mL/m 2 ; P=0.403). The LVEF values in the patients with ischemic heart disease (range, 50%-53%) were still in ranges similar to those observed in the control subjects (range, 50%-64%). In addition, patients treated with IVIG (n=53) did not differ significantly from nontreated patients (n=7).
Both observers agreed on the absence, presence, and extent of late enhancement. Late enhancement was observed in only 2 of the 60 KD patients. One patient had a mid/apical inferior area of subendocardial enhancement; the other patient had a basal/mid inferior area of transmural contrast enhancement (Figure) . In both patients, the enhancement was detected in territories of affected coronary arteries and involved the subendocardium, typical for myocardial infarction. 24, 25 This observation is supported by the clinical history of the patients, who both had giant CAAs and had undergone a coronary artery bypass grafting procedure. Typical lesions of myocarditis with a subepicardial or midwall distribution that are mostly located in the lateral wall or the intraventricular septum 18, 25 were not observed.
Follow-up CMRI
One of 15 patients refused the CMRI reexamination. In 14 patients, a second CMRI was performed after a mean interval of 22±9 months (range, 8-38 months). The follow-up studies revealed no significant differences in biventricular volumes compared with the first CMRIs (LVEDV/BSA, 104 versus 101 mL/ m²; LVESV/BSA, 47 versus 46 mL/m²; RVEDV/BSA, 106 versus 102 mL/m²; RVESV/BSA, 51 versus 49 mL/m², respectively). There were also no differences in biventricular EFs between both CMRIs (LVEF, 55% versus 54%; RVEF, 52% versus 53%).
Intraobserver and Interobserver Variabilities
Intraobserver variability for the biventricular volumes was good (coefficient of variation, 3.4%-8.4%), with slightly higher variations in the measurements of the RV. Intraclass correlation coefficients for all parameters were >0.92, except for LVEF and RVEF (0.886 and 0.607, respectively). Patterns for interobserver variability mirrored those for intraobserver variability. Data are shown in Table II in the online-only Data Supplement.
Discussion
This is the first CMRI study evaluating biventricular volumes and function in patients with a history of KD compared with healthy control subjects. We observed no significant difference in biventricular volumes and function at long-term follow-up between patients and control subjects, except for a subgroup of patients with severe coronary artery pathology. This is in line with our earlier observations in a comparable patient population that, in general, no segmental wall motion abnormalities are present at long-term follow-up. 26 This encouraging result contrasts with some of the previous histopathologic studies that have indicated persistent changes after KD. It is generally assumed that myocarditis may occur in KD, and prior histopathologic studies indeed reported myocardial abnormalities during the acute phase but also during follow-up. 12, 27 Yonesaka et al 27 reported myocardial changes, including interstitial fibrosis, degeneration of myocytes, and disarray, in cardiac biopsies of 38 patients >2 years after disease onset. In a larger study of 201 patients by Yutani et al, 12 abnormalities of the myocardium were observed in every biopsy specimen and at all time points after KD (interval, 2 months to 11 years). The severity of the changes was unrelated to the presence of CAA, and changes were even more pronounced ≥4 years after disease onset. 12 If chronic cardiomyopathy may indeed occur, this process would be expected to ultimately result in (subtle) ventricular dysfunction. However, such dysfunction was not noticed in our follow-up cohort. In addition, we did not observe late enhancement caused by myocardial fibrosis in any of the patients except for 2 individuals with a history of myocardial infarction. A possible explanation is the interval between disease onset and CMRI examination, rendering time for successful remodeling and healing. Another and more likely explanation is that-in contrast to large areas of myocardium affected by ischemic processesthe prior myocarditis-related damage cannot be detected on CMRI because of its diffuse and limited nature. This is supported by a recent study by Mavrogeni et al. 28 CMRIs were performed in 13 patients during the reconvalescence of KD (20-40 days after the onset of disease). Both early enhancement and T2-weighted analysis were highly suggestive of an active inflammatory process in 6 of 13 patients (46%). Late enhancement was identified in 3 of these 6 patients. The authors suggest that the lack of late enhancement in 3 patients may be explained by the nature of the myocarditis, being characterized by inflammatory infiltration from the coronary arteries to the interstitial myocardium, and therefore myocardial necrosis is not observed frequently.
Reports on cardiac function during the long-term follow-up of KD are limited. Prior echocardiography studies reported relatively short follow-up intervals and produced conflicting results. Most investigators reported resolution of dysfunction during reconvalescence, but 1 study reported long-term abnormalities of LV size and function. 4, 5, 7 Our CMRI study supports a favorable outcome at long-term follow-up (mean interval, 12.0 years [range 0.6-20.7 years]), even in patients with persistent CAAs and myocardial ischemic injury in the past. One of the possible explanations for such an encouraging outcome may be that the majority of patients have received IVIG. Newburger et al 7 showed that LV functional abnormalities improved more rapidly in patients treated with IVIG and aspirin compared with patients who were treated with aspirin alone. In addition, Moran et al 5 observed that LV contractility normalized within 24 hours after IVIG infusion in more than half of the patients with depressed contractility at baseline. Although the working mechanism of IVIG has not yet been defined, it is reasonable that IVIG therapy decreases the long-term myocardial abnormalities, just as it decreases the incidence of CAAs. 3 We did not observe any statistically significant difference in biventricular volumes or between patients who had been treated with IVIG and those who were not treated, but the number of patients in the nontreated group was limited (n=7).
CMRI is now the reference standard for the assessment of ventricular dimensions and function. 16 Prior CMRI studies in KD are limited and have focused mainly on the coronary artery sequelae. 26, [29] [30] [31] [32] To date, 1 study by Mavrogeni et al 31 reported functional CMRI data of 20 patients with persistent CAAs. In all patients except 2 with prior myocardial infarction, the LVEF was found to be within normal values. The results of our study on a larger cohort of 60 patients and 20 control subjects are consistent with these prior findings. In the recent CMRI study by Mavrogeni et al 28 in 13 patients described previously, LVEF was lower in patients with inflammation compared with those without inflammation during reconvalescence (49.8% versus 62.3%; P<0.001). However, a comparison with normal values was not reported, and although patients were reported to be reevaluated after 3 months, functional follow-up data were not described. 28 Several investigators have reported mean normal values for CMRI indexes in healthy subjects, but these studies overall reported lower biventricular EDV and ESV and higher EF than we found in the present study (Table 3) . [33] [34] [35] [36] [37] [38] [39] [40] [41] The differences may be explained by the age range of the study population, the use of different CMRI techniques, and the use of different image analysis protocols. 33, 36, 37, 39, [42] [43] [44] For instance, the inclusion of papillary muscles in the ventricular volumes leads to a significantly higher LVEDV and LVESV and significantly lower calculated LVEF. 43, 44 There is currently no consensus on which method of tracing should be used. We have included these structures because of shorter time analysis and better interobserver and interexamination variabilities. 43, 44 Furthermore, we examined a group of healthy control subjects for comparison using the same CMRI and image analysis protocols. Intraobserver and interobserver variabilities for the CMRI variables in our study were good and comparable to those in other CMRI studies. 35, 39 The proportion of patients with CAAs in our study (32%) was high compared with the literature (<10%). 2, 3 This could be explained by referral bias with the more severe cases being referred to our tertiary center and by more frequent follow-up of CAA-positive patients. Our study found encouraging results for the more seriously affected patients with persistent CAAs or ischemic heart disease in the past. Although these results are reassuring, we advise some form of periodic monitoring of cardiac function in affected patients because of the risk of possible deterioration over time until more patient data are available over longer periods of follow-up. CMRI may be suitable for serial evaluation, combining coronary artery surveillance and functional evaluation in 1 examination without the use of radiation or an invasive procedure. 26 There are some limitations of the study. First, we do not have CMRI data of the acute phase; therefore, the course over time cannot be assessed. Second, the follow-up time after KD was ≈10 years. Although cardiac function seems unimpaired, assessment at longer periods must await further follow-up. Third, although relatively large compared with earlier studies of this rare disease, the numbers of subjects were small, so type II errors cannot be ruled out. However, ventricular data of patients and control subjects agreed closely, making it unlikely that differences would have been found in much larger sample sizes. Post hoc power calculations showed that our study had 80% power to pick up a mean difference of ≥3% in LVEF between patients and control subjects at a 0.05 significance level. From a clinical perspective, we believe that if between-group differences were going undetected because our study was underpowered, these differences are small and may clinically not be very relevant. 45 Fourth, patients may have been misclassified in the subgroup analysis because of the retrospective design of the clinical data collection. They may additionally have been misclassified in the CAA subgroup analysis because the definition of a CAA was based on the Japanese Ministry of Health criteria instead of z scores. 46 We used these criteria because they are still routinely used in our clinical practice and because not all data on length and weight could be retrieved retrospectively to calculate BSA. Fifth, CMRI found late segmental enhancement in 2 patients but may not have been able to detect more subtle, diffuse fibrosis. The study also did not assess diastolic function or ventricular strain. These may be targets for further study. Finally, multiple comparisons have been made, increasing the possibility of finding differences by chance. However, because overall no significant differences have been found, this limitation is in our view of limited importance.
Conclusions
Although prior histopathologic studies suggest persistent myocardial abnormalities after KD, we did not observe a significant difference in cardiac function at long-term follow-up between KD patients and control subjects, except for a subgroup of patients with ischemic heart disease. Late enhancement was detected only in patients with severe coronary artery pathology or prior myocardial infarction.
